Oligodendroglioma: Clinical Trials

7 trials for Oligodendroglioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7
Phase 21Completed 1

Follow Oligodendroglioma: new trials by email Literature Review of Oligodendroglioma trials Research Report on Oligodendroglioma

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
donepezil hydrochloride, Placebo - Brain Tumors, Metastatic Disease
Phase 3CompletedWake Forest University Health Sciences1982008-02-012021-10-20
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
temozolomide, radiation therapy - Brain and Central Nervous System Tumors
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC7092005-07-012016-10-12
Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Temozolomide, Focal radiotherapy - Anaplastic Astrocytoma, Oligodendroglioma
Phase 3CompletedNeuro-Oncology Working Group of the German Cancer Society3181999-06-012008-07-17
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
lomustine, procarbazine hydrochloride, vincristine sulfate - Brain and Central Nervous System Tumors
Phase 2 / Phase 3CompletedRadiation Therapy Oncology Group3701998-10-012024-07-09
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
lomustine, procarbazine hydrochloride, vincristine sulfate - Brain and Central Nervous System Tumors
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC3501996-08-012012-07-10
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
lomustine, procarbazine hydrochloride, vincristine sulfate - Brain and Central Nervous System Tumors
Phase 3CompletedRadiation Therapy Oncology Group2991994-07-012018-06-18

Narrower conditions

Astrocytoma (5)  ·  Glioma (5)  ·  Central Nervous System Neoplasms (4)  ·  Brain Neoplasms (3)  ·  Choroid Plexus Neoplasms (2)  ·  Craniopharyngioma (2)  ·  Ependymoma (2)  ·  Glioblastoma (2)  ·  Glioma, Subependymal (2)  ·  Gliosarcoma (2)  ·  Medulloblastoma (2)  ·  Meningioma (2)  ·  Neuroectodermal Tumors, Primitive (2)  ·  Pinealoma (2)

Broader conditions

Neoplasms by Histologic Type (7)  ·  Neoplasms, Germ Cell and Embryonal (7)  ·  Neoplasms, Glandular and Epithelial (7)  ·  Neoplasms, Nerve Tissue (7)  ·  Neoplasms, Neuroepithelial (7)  ·  Neuroectodermal Tumors (7)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Nervous System Diseases (6)  ·  Nervous System Neoplasms (6)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Neoplasms (2)  ·  Cerebral Ventricle Neoplasms (2)  ·  Glioma (2)

Interventions

Radiotherapy (4)  ·  Lomustine (3)  ·  Procarbazine (3)  ·  Vincristine (3)  ·  Temozolomide (2)  ·  Donepezil (1)  ·  Fentanyl (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Radiation Therapy Oncology Group (2)  ·  INSYS Therapeutics Inc (1)  ·  Neuro-Oncology Working Group of the German Cancer Society (1)  ·  Wake Forest University Health Sciences (1)

Countries

Germany (3)  ·  United States (3)  ·  Austria (2)  ·  Belgium (2)  ·  France (2)  ·  Hungary (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Portugal (2)  ·  Sweden (2)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Canada (1)  ·  Egypt (1)

Top investigators

Brigitta Baumert, MD, PhD (1)  ·  Edward G. Shaw, MD (1)  ·  Geoffrey R. Barger, MD (1)  ·  J. Gregory Cairncross, MD (1)  ·  Jan C. Buckner, MD (1)  ·  Karen L. Fink, MD, PhD (1)  ·  Larry Dillaha, MD (1)  ·  Michael Weller, MD (1)  ·  Minesh P. Mehta, MD (1)  ·  Normand Laperriere, MD, FRCPC (1)  ·  Richard M. Hellman, MD (1)  ·  Roger Stupp, MD (1)  ·  Stephen Rapp, PhD (1)  ·  Steven R. Alberts, MD (1)

Results publications

PMID 35731991, PMID 11586105, PMID 16782910, PMID 16782911, PMID 17549014, PMID 18089866, PMID 18089867, PMID 18371182, PMID 18976072, PMID 19224764, PMID 19783377, PMID 19901104, PMID 20160062, PMID 20820870, PMID 21246521, PMID 21914791, PMID 22480131, PMID 22851558, PMID 23071237, PMID 23071247, PMID 23269986, PMID 24419119, PMID 27020837, PMID 27050206, PMID 27370396, PMID 27686943, PMID 27686946, PMID 29571083, PMID 32706640

NIH funding

2004 (1), U10CA081851 (1)